Fighting infection: an ongoing challenge, part 2--antibacterials

Beatrice B Turkoski1

  • 1Advanced Practice Nursing, Kent State University College of Nursing, Kent, OH, USA.

Orthopedic Nursing
|June 2, 2005
PubMed

Insights

This review details antibacterial agents targeting bacterial infections, including cell wall, protein synthesis, and nucleic acid inhibitors. It covers their uses, mechanisms, side effects, and patient education for judicious antimicrobial use.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antimicrobials are crucial for treating infections but face growing resistance.
  • Judicious use of antimicrobials is essential to combat resistance.
  • This section focuses on antibacterial agents, a key class of antimicrobials.

Purpose of the Study:

  • To provide an overview of antibacterial agents used in medicine.
  • To discuss specific classes of antibacterials: cell wall inhibitors, protein synthesis inhibitors, and nucleic acid inhibitors.
  • To detail the use, mechanism of action, and adverse effects of various antibacterial agents.

Main Methods:

  • Literature review of established antibacterial drug classes.
  • Categorization of antibacterials based on their molecular targets (cell wall, protein synthesis, nucleic acid).
  • Inclusion of examples, clinical applications, and safety profiles for each class.

Main Results:

  • Detailed discussion of penicillins, cephalosporins (cell wall inhibitors).
  • Overview of macrolides, tetracyclines, aminoglycosides (protein synthesis inhibitors).
  • Examination of sulfonamides, quinolones (nucleic acid inhibitors) with examples and adverse effects.

Conclusions:

  • Understanding antibacterial mechanisms is key to effective treatment.
  • Awareness of adverse effects and proper patient teaching are vital for safe and effective antibacterial therapy.
  • This review supports a more judicious approach to antibacterial prescribing.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: